PE/Cyanine5.5 Anti-Mouse CD274/PD-L1 Antibody[10F.9G2]

PE/Cyanine5.5 Anti-Mouse CD274/PD-L1 Antibody[10F.9G2]

Introducing the PE/Cyanine5.5 Anti-Mouse CD274/PD-L1 Antibody [10F.9G2], a highly advanced and meticulously crafted product designed to revolutionize the field of immunology research. This antibody, meticulously developed using cutting-edge technology, offers unparalleled specificity and sensitivity in detecting and analyzing CD274/PD-L1 expression in mouse samples.

With its exceptional performance, this antibody enables researchers to delve deeper into the intricate mechanisms of immune regulation and explore the role of CD274/PD-L1 in various physiological and pathological processes. Its unique formulation, incorporating the powerful PE/Cyanine5.5 fluorochrome, ensures optimal signal detection and minimal background noise, facilitating accurate and reliable results.

The PE/Cyanine5.5 Anti-Mouse CD274/PD-L1 Antibody [10F.9G2] boasts an exceptional affinity for CD274/PD-L1, allowing for precise identification and quantification of this critical immune checkpoint molecule. Its high specificity ensures minimal cross-reactivity, guaranteeing the utmost accuracy in experimental outcomes.

This antibody is meticulously manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reproducibility. Its exceptional stability and long shelf life make it an ideal choice for long-term experiments and storage.

The PE/Cyanine5.5 Anti-Mouse CD274/PD-L1 Antibody [10F.9G2] is compatible with a wide range of applications, including flow cytometry, immunofluorescence, and immunohistochemistry. Its versatility allows researchers to explore CD274/PD-L1 expression in various cell types, tissues, and experimental models, providing invaluable insights into the complex interplay between the immune system and disease progression.

In summary, the PE/Cyanine5.5 Anti-Mouse CD274/PD-L1 Antibody [10F.9G2] represents a breakthrough in immunological research, offering exceptional sensitivity, specificity, and versatility. With its unrivaled performance and meticulous design, this antibody is poised to revolutionize the understanding of CD274/PD-L1 biology and pave the way for groundbreaking discoveries in the field of immunotherapy.